Article Sidebar
Published:
Sep 16, 2020Keywords:
African network; African scientists; vaccine research; diseases
Article Details
Issue
Section
Articles
Brief summary of the agreement
Anyone is free:
· to copy, distribute, and display the work;
· to make derivative works;
· to make commercial use of the work;
Under the following conditions: Attribution
· the original author must be given credit;
· for any reuse or distribution, it must be made clear to others what the license terms of this work are;
· any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above
Main Article Content
African Vaccinology Network (AfVANET): an African network by African scientists
David Dazhia Lazarus
Faculty of Veterinary Science, University of Pretoria, Pretoria, South Africa; National Veterinary Research Institute, Vom, Plateau, Nigeria
Funmilayo Ibitayo Deborah Afolayan
Department of Zoology, University of Ibadan, Ibadan, Nigeria
Gezahegne Mamo
College of Veterinary Medicine and Agriculture, Addis Ababa University, Addis Ababa, Ethiopia
Jerome Nyhalah Dinga
Biotechnology Unit, University of Buea, Buea, Cameroon
Jones Akinbobola
Faculty of Veterinary Medicine, Department of Veterinary Medicine, University of Abuja, Abuja, Nigeria
Kwabena Obeng Duedu
Department of Biomedical Sciences, University of Health and Allied Sciences, Ho, Ghana
Nefefe Tshifhiwa
ARC-Onderstepoort Veterinary Research, Pretoria, South Africa
Tesfaye Kassa
School of Medical Laboratory Science, Institute of Health, Jimma University, Jimma, Ethiopia
Vish Nene
International Livestock Research Institute, Nairobi, Kenya
Yakhya Dieye
University Cheikh Anta Diop and Pasteur Institute, Dakar, Senegal
Mustapha Oumouna
Faculty of Sciences, University of Médéa, Médéa, Algeria
Abstract
We write to introduce the African Vaccinology Network (AfVANET) as a new network of African research scientists involved in vaccine research and development (R&D) for human and animal diseases. The goal of this network is to promote and build capacity for early phase vaccine R&D in Africa in order to stimulate the development of innovative solutions to combat diseases that affect the continent.